Winton Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.1M | Buy |
95,211
+19,477
| +26% | +$224K | 0.06% | 399 |
|
2025
Q1 | $1.14M | Buy |
75,734
+26,111
| +53% | +$391K | 0.07% | 303 |
|
2024
Q4 | $859K | Buy |
49,623
+2,683
| +6% | +$46.4K | 0.06% | 377 |
|
2024
Q3 | $870K | Sell |
46,940
-13,070
| -22% | -$242K | 0.06% | 350 |
|
2024
Q2 | $1.22M | Buy |
60,010
+4,147
| +7% | +$84.1K | 0.08% | 173 |
|
2024
Q1 | $954K | Buy |
+55,863
| New | +$954K | 0.07% | 293 |
|
2022
Q3 | – | Sell |
-17,755
| Closed | -$352K | – | 962 |
|
2022
Q2 | $352K | Sell |
17,755
-3,297
| -16% | -$65.4K | 0.02% | 774 |
|
2022
Q1 | $666K | Buy |
21,052
+2,764
| +15% | +$87.4K | 0.03% | 599 |
|
2021
Q4 | $408K | Sell |
18,288
-15,778
| -46% | -$352K | 0.02% | 735 |
|
2021
Q3 | $945K | Buy |
34,066
+3,351
| +11% | +$93K | 0.05% | 537 |
|
2021
Q2 | $1.2M | Sell |
30,715
-2,962
| -9% | -$115K | 0.06% | 428 |
|
2021
Q1 | $970K | Sell |
33,677
-7,561
| -18% | -$218K | 0.06% | 477 |
|
2020
Q4 | $1.09M | Sell |
41,238
-69,914
| -63% | -$1.85M | 0.08% | 358 |
|
2020
Q3 | $1.7M | Sell |
111,152
-65,449
| -37% | -$999K | 0.06% | 609 |
|
2020
Q2 | $3.59M | Sell |
176,601
-32,815
| -16% | -$667K | 0.09% | 370 |
|
2020
Q1 | $2.17M | Buy |
209,416
+79,812
| +62% | +$825K | 0.06% | 550 |
|
2019
Q4 | $4.88M | Buy |
129,604
+114,850
| +778% | +$4.33M | 0.07% | 477 |
|
2019
Q3 | $688K | Buy |
+14,754
| New | +$688K | 0.01% | 980 |
|